Cargando…
Adjuvant Systemic Anti-cancer Therapy in Early Breast Cancer During the COVID-19 Pandemic: Differences between Clinicians and Patients in Perception of Treatment Risks and Benefits
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Royal College of Radiologists. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280104/ https://www.ncbi.nlm.nih.gov/pubmed/32536560 http://dx.doi.org/10.1016/j.clon.2020.06.001 |
| _version_ | 1783543679386910720 |
|---|---|
| author | Gatfield, E.R. Mukesh, M.B. Loo, S.W. |
| author_facet | Gatfield, E.R. Mukesh, M.B. Loo, S.W. |
| author_sort | Gatfield, E.R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7280104 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | The Royal College of Radiologists. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72801042020-06-09 Adjuvant Systemic Anti-cancer Therapy in Early Breast Cancer During the COVID-19 Pandemic: Differences between Clinicians and Patients in Perception of Treatment Risks and Benefits Gatfield, E.R. Mukesh, M.B. Loo, S.W. Clin Oncol (R Coll Radiol) Letter The Royal College of Radiologists. Published by Elsevier Ltd. 2020-10 2020-06-09 /pmc/articles/PMC7280104/ /pubmed/32536560 http://dx.doi.org/10.1016/j.clon.2020.06.001 Text en © 2020 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter Gatfield, E.R. Mukesh, M.B. Loo, S.W. Adjuvant Systemic Anti-cancer Therapy in Early Breast Cancer During the COVID-19 Pandemic: Differences between Clinicians and Patients in Perception of Treatment Risks and Benefits |
| title | Adjuvant Systemic Anti-cancer Therapy in Early Breast Cancer During the COVID-19 Pandemic: Differences between Clinicians and Patients in Perception of Treatment Risks and Benefits |
| title_full | Adjuvant Systemic Anti-cancer Therapy in Early Breast Cancer During the COVID-19 Pandemic: Differences between Clinicians and Patients in Perception of Treatment Risks and Benefits |
| title_fullStr | Adjuvant Systemic Anti-cancer Therapy in Early Breast Cancer During the COVID-19 Pandemic: Differences between Clinicians and Patients in Perception of Treatment Risks and Benefits |
| title_full_unstemmed | Adjuvant Systemic Anti-cancer Therapy in Early Breast Cancer During the COVID-19 Pandemic: Differences between Clinicians and Patients in Perception of Treatment Risks and Benefits |
| title_short | Adjuvant Systemic Anti-cancer Therapy in Early Breast Cancer During the COVID-19 Pandemic: Differences between Clinicians and Patients in Perception of Treatment Risks and Benefits |
| title_sort | adjuvant systemic anti-cancer therapy in early breast cancer during the covid-19 pandemic: differences between clinicians and patients in perception of treatment risks and benefits |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280104/ https://www.ncbi.nlm.nih.gov/pubmed/32536560 http://dx.doi.org/10.1016/j.clon.2020.06.001 |
| work_keys_str_mv | AT gatfielder adjuvantsystemicanticancertherapyinearlybreastcancerduringthecovid19pandemicdifferencesbetweencliniciansandpatientsinperceptionoftreatmentrisksandbenefits AT mukeshmb adjuvantsystemicanticancertherapyinearlybreastcancerduringthecovid19pandemicdifferencesbetweencliniciansandpatientsinperceptionoftreatmentrisksandbenefits AT loosw adjuvantsystemicanticancertherapyinearlybreastcancerduringthecovid19pandemicdifferencesbetweencliniciansandpatientsinperceptionoftreatmentrisksandbenefits |